AJMC Staff

World Pneumonia Day is Saturday, November 12, and health organizations issued a call to action to do a better job of diagnosing, treating, and preventing the disease.

Prior to this first therapy for repigmentation being approved, the only approved therapy was a depigmenting agent, which is usually the opposite of what providers are trying to accomplish with treatment.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The latest update says that Janus kinase (JAK) inhibitors should only be used if risk factors for cardiovascular disease or cancer have been considered, and that biologics are preferred.

Abortion rights measures on the ballot saw victories in all 5 states; South Dakota voted to expand access to Medicaid; rates of inflammatory heart conditions were increased in people with the second dose of the Moderna COVID-19 vaccine.

The Department of Veterans Affairs (VA) will give cancer claims priority when a new law takes effect in January 2023; Pfizer is looking to use its COVID-19 profits to grow other blockbusters; the probable loss of Medicaid coverage for millions next year is setting off debate.

The Supreme Court will hear a nursing home case Tuesday that could have far-reaching consequences; COVID-19 is continuing to take a toll on worker productivity; ultra-processed foods are linked to premature deaths in a new study.

More than 1 in 4 adults have 1 or more conditions that fall into the cardio-renal-metabolic category, according to findings released during Kidney Week 2022.

Since endometriosis is a chronic disease, treating it cannot be approached with a “one-and-done” mentality, said Soyini Hawkins, MD, gynecologist at Fibroid and Pelvic Wellness Center of Georgia.

Pfizer’s updated COVID-19 booster was found to be nearly 4 times more efficacious against Omicron in older adults; CDC released more flexible guidelines for clinicians prescribing opioids; Senator Mark Warner released a report offering solutions to cybersecurity threats to the health care sector.

The HHS renewed the national public health emergency for the monkeypox outbreak in the United States; more demand for amoxicillin has led to a nationwide shortage as respiratory illnesses continue to spread; a drug already approved for weight loss in adults has demonstrated promise in teenagers aged 12 to 17 years.

FDA advisers met to discuss alternatives to the infrared light used in pulse oximeters, which can be absorbed by melanin; FDA warns of a national shortage of tracheostomy tubes, especially for pediatric patients; 1 in 5 deaths among adults aged between 20 and 49 years is due to excessive drinking.

Pfizer’s maternal respiratory syncytial virus (RSV) vaccine was found to be highly effective in infants' first 6 months of life; survey shows long COVID-19 is more common among women than men; some voters worry that a Republican-controlled Congress could put science and science policy on the line.

Atopic dermatitis is a common disease that has seen an explosion of new treatments in the last decade, explained Peter A. Lio, MD, clinical assistant professor of pediatrics and dermatology, Northwestern Feinberg School of Medicine.

The legal abortion rate has fallen 6% since the overturning of Roe v Wade; 30% of patients with COVID-19 experienced a rebound in symptoms after 2 consecutive days without; open enrollment for Affordable Care Act marketplace insurance begins this week.

The number of tuberculosis cases has risen by 4.5% from 2021; Black and Hispanic patients with COVID-19 were less likely to receive paxlovid in 2022; a new report highlights declines in US cancer death rates between 2015 and 2019.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A recent study found that Americans die younger in states with conservative policies; most patients admitted to the hospital with monkeypox also have HIV; 4 million children are uninsured due to state policies, according to new research.

Black and Latino Americans saw surges in health care insurance enrollment through the Affordable Care Act (ACA) between 2020 and 2022; Medicaid enrollment and spending is expected to slow in 2023; the Biden administration is preparing a national hepatitis C treatment plan.

The study sought to examine the safety and tolerability of gefapixant in Japanese patients with refractory or unexplained chronic cough.

CVS Health and a digital diagnostic startup will produce at-home tests for vitamin D, Lyme disease, sexually transmitted infections, and thyroid function; researchers identified 42 genetic variants associated with dyslexia; FDA plans updated mammogram regulations to help women with dense breasts.

A dual immunotherapy option of tremelimumab, sold as Imjudo, in combination with durvalumab, sold as Imfinzi, was approved by the FDA Monday for the treatment of adult patients with unresectable hepatocellular carcinoma, the most common type of liver cancer.

The Biden administration will expand the use of medication to treat substance use disorders to include pregnant women; oversight of the nation’s poorest-performing nursing homes will be tightened; children’s hospitals are filling up with cases of respiratory syncytial virus and other respiratory diseases.

New research is identifying the recipient and donor factors that allow for greater longevity for certain livers after transplantation.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

CDC advisory group votes to add COVID-19 vaccines to the pediatric immunization schedule; a new report says workplaces can be hazardous to the mental and physical health of Americans; drug makers are lobbying to ease the impact of the Inflation Reduction Act.

Endometriosis can have a long timeline from onset of symptoms to diagnosis, and in later stages it can affect organs other than the uterus, explained Soyini Hawkins, MD, gynecologist at Fibroid and Pelvic Wellness Center of Georgia.

Experts advised the FDA to withdraw a preterm birth treatment from the market; the Novavax booster for COVID-19 was approved by US regulators on Wednesday; allergy medication was found to be commonly present in those who died of an opioid overdose.

The White House launched a national biodefense strategy to protect the country from future pandemics and biological threats; researchers found racial disparities in infant deaths following fertility treatments; global leaders pledged a total of $2.6 billion toward the Global Polio Eradication Initiative’s 2022-2026 Strategy.